Cargando…
Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication
BACKGROUND: Multiple myeloma (MM) is a distinctive malignancy of plasma cell within the bone marrow (BM), of which alternative splicing factors play vital roles in the progression. Splicing factor arginine/serine‐rich 8 (SFRS8) is the exclusive factor associated with MM prognosis, however its role i...
Autores principales: | Zhang, Yuanjiao, Yu, Xichao, Sun, Rongze, Min, Jie, Tang, Xiaozhu, Lin, Zigen, Xie, Siyuan, Li, Xinying, Lu, Shengfeng, Tian, Zhidan, Gu, Chunyan, Teng, Lesheng, Yang, Ye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858635/ https://www.ncbi.nlm.nih.gov/pubmed/35184390 http://dx.doi.org/10.1002/ctm2.684 |
Ejemplares similares
-
Correction to“Splicing factor arginine/serine‐rich 8 promotes multiple myeloma malignancy and bone lesion through alternative splicing of CACYBP and exosome‐based cellular communication”
Publicado: (2023) -
Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020) -
Towards understandings of serine/arginine-rich splicing factors
por: Li, Dianyang, et al.
Publicado: (2023) -
Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β
por: Hallgren, Oskar, et al.
Publicado: (2012) -
Serine/arginine-rich splicing factors belong to a class of intrinsically disordered proteins
por: Haynes, Chad, et al.
Publicado: (2006)